Fig. 2From: Sevoflurane inhibits the progression of ovarian cancer through down-regulating stanniocalcin 1 (STC1)Sevoflurane induces cell cycle arrest in ovarian cancer cells. a SKOV3 and OVCAR3 cells were treated with sevoflurane for 24 h, the cell cycle distribution was analysed by flow cytometry. b Cells were incubated with sevoflurane for 48 h, the expression of Cyclin D1 and CDK4 was examined using western blot analysis. The data were expressed as the mean ± SD from three independent experiments. *P < 0.05 vs. the negative control groupBack to article page